Rapt Therapeutics (RAPT)
(Delayed Data from NSDQ)
$7.90 USD
-0.10 (-1.25%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $7.90 0.00 (0.00%) 6:36 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | -0.78 |
EPS Last Quarter | -0.80 |
Last EPS Surprise | 5.88% |
ABR | 1.83 |
Earnings ESP
|
-0.96% |
---|---|
Current Year | -3.19 |
Next Year | -2.40 |
EPS (TTM) | -3.04 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | 1.53M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.78 | -0.80 | -3.19 | -2.40 |
# of Estimates | 4 | 4 | 6 | 3 |
Most Recent Consensus | -0.80 | -0.83 | -3.26 | -2.53 |
High Estimate | -0.72 | -0.68 | -2.54 | -1.57 |
Low Estimate | -0.82 | -0.88 | -4.12 | -3.09 |
Year ago EPS | -0.76 | -0.66 | -3.05 | -3.19 |
Year over Year Growth Est. | -2.63% | -21.21% | -4.59% | 24.76% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 3 | 3 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 1 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.78 | -0.80 | -3.19 | -2.40 |
7 Days Ago | -0.78 | -0.80 | -3.19 | -2.40 |
30 Days Ago | -0.80 | -0.81 | -3.21 | -2.65 |
60 Days Ago | -0.83 | -0.86 | -3.32 | -2.98 |
90 Days Ago | -0.82 | -0.83 | -3.46 | -3.96 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.79 | -0.80 | -2.54 | -1.57 |
Zacks Consensus Estimate | -0.78 | -0.80 | -3.19 | -2.40 |
Earnings ESP | -0.96% | -0.31% | 20.29% | 34.49% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.80 | -0.82 | -0.66 | -0.76 | NA |
Estimate | -0.85 | -0.75 | -0.80 | -0.64 | NA |
Difference | 0.05 | -0.07 | 0.14 | -0.12 | 0.00 |
Surprise | 5.88% | -9.33% | 17.50% | -18.75% | -1.18% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more